» Articles » PMID: 35160218

Pulmonary Tuberculosis and Risk of Lung Cancer: A Systematic Review and Meta-Analysis

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Feb 15
PMID 35160218
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary tuberculosis (TB) is a known risk factor for lung cancer. However, a detailed analysis of lung cancer type, age, sex, smoking, and TB burden associated with geographic and socioeconomic status has not been performed previously. We systematically appraised relevant observational studies reporting an association between pulmonary TB and lung cancer. All studies were included in the primary analysis, and studies that used robust TB diagnostic methods, such as validated medical diagnostic codes, were included in the secondary analysis. Thirty-two articles were included. The association between the history of pulmonary TB and diagnosis of lung cancer was statistically significant (OR 2.09, 95% CI: 1.62-2.69, < 0.001). There was a high heterogeneity ( = 95%), without any publication bias. The analysis indicated a high association in advanced articles describing stringent pulmonary TB diagnosis (OR 2.26, 95% CI: 1.29-3.94, = 0.004). The subgroup analyses suggested a significant association in countries with medium or high TB burdens, from East Asia and the Pacific region, and upper-middle income countries. Heterogeneity within the subgroups remained high in a majority of the subgroup analyses. A meta-regression analysis revealed that younger patients showed a significantly higher association between TB and lung cancer (regression coefficient = 0.949, < 0.001). The history of pulmonary TB is an independent risk factor for lung cancer, especially in younger patients diagnosed with pulmonary TB. Clinicians should be aware of this association while treating young patients with a history of pulmonary TB.

Citing Articles

infection may increase the degrees of malignancy in lung adenocarcinoma.

Li S, Feng M, Wang F, Liu D, Li M, Dai J Front Immunol. 2025; 16:1537520.

PMID: 40061944 PMC: 11885956. DOI: 10.3389/fimmu.2025.1537520.


Pulmonary sarcomatoid carcinoma coexisting with tuberculosis: a case report and literature review.

Huang Z, Zhu Y, Zeng Y, Huang H, Liu J, Cen W Front Oncol. 2025; 14:1492574.

PMID: 39868375 PMC: 11757094. DOI: 10.3389/fonc.2024.1492574.


Clinical and imaging features of co-existent pulmonary tuberculosis and lung cancer: a population-based matching study in China.

Zhang F, Qi F, Han Y, Yang H, Wang Y, Wang G BMC Cancer. 2025; 25(1):89.

PMID: 39815214 PMC: 11734471. DOI: 10.1186/s12885-024-13350-y.


Risk of TB disease in individuals with cancer.

Diefenbach-Elstob T, Tabrizi S, Rivest P, Benedetti A, Azoulay L, Schwartzman K IJTLD Open. 2025; 2(1):45-52.

PMID: 39802228 PMC: 11724530. DOI: 10.5588/ijtldopen.24.0440.


Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches.

Bartolomeu-Goncalves G, Souza J, Fernandes B, Spoladori L, Correia G, Castro I Diseases. 2024; 12(9).

PMID: 39329871 PMC: 11430992. DOI: 10.3390/diseases12090202.


References
1.
Brenner D, McLaughlin J, Hung R . Previous lung diseases and lung cancer risk: a systematic review and meta-analysis. PLoS One. 2011; 6(3):e17479. PMC: 3069026. DOI: 10.1371/journal.pone.0017479. View

2.
Gorlova O, Zhang Y, Schabath M, Lei L, Zhang Q, Amos C . Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2005; 118(7):1798-804. DOI: 10.1002/ijc.21561. View

3.
Chai Q, Lu Z, Liu Z, Zhong Y, Zhang F, Qiu C . Lung gene expression signatures suggest pathogenic links and molecular markers for pulmonary tuberculosis, adenocarcinoma and sarcoidosis. Commun Biol. 2020; 3(1):604. PMC: 7584606. DOI: 10.1038/s42003-020-01318-0. View

4.
Hwang I, Paik S, Lee S . Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung Adenocarcinoma. Cancer Res Treat. 2018; 51(1):158-168. PMC: 6333978. DOI: 10.4143/crt.2018.084. View

5.
Shiels M, Albanes D, Virtamo J, Engels E . Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2011; 20(4):672-8. PMC: 3076700. DOI: 10.1158/1055-9965.EPI-10-1166. View